News

Breakthrough Cancer Research, Ireland’s leading medical research charity focused on cancer awareness and funding cutting-edge science, is bringing the acclaimed Cancer Revolution: Science, Innovation and Hope exhibition to Ireland for the very first time.

We are pleased to invite the submission of abstracts for Symposium M, an international symposium organized within the 2026 European Materials Research Society Fall Meeting in Warsaw, where Prof. Silvia Giordani will serve as Chair, together with joint organizers Dr.

Nanoparticles for Drug Delivery and Therapy 8-9 June | Dublin City University, Glasnevin Campus

The smiles have not yet faded, and the excitement of the challenges ahead is still fuelling the energy of more than 25 international researchers as they return to their laboratories.

The Giordani Group is delighted to welcome Dr. Wanting Zhang as a Postdoctoral Researcher. Her work is supported by funding from the Research Ireland Frontiers for the Future Award awarded to Prof.

On 20 March 2026, the Nanoparticles for Drug Delivery & Therapy Workshop was held at Bangor University organised by our collaborator Prof. Zengbo Wang and his team. The programme featured a keynote lecture by Prof.

We are delighted to welcome Francesco Bellina to the team as a postdoctoral researcher, funded by the European Innovation Council (EIC). Francesco completed is BsC and MsC in Chemistry from the University of Genoa and obtained his PhD from the Italian Institute of Technology (Italy).

In a recent feature, the Italian newspaper highlights her research on carbon nano-onions as promising nanocarriers for targeted cancer therapy.

Professor Silvia Giordani has been awarded the 2025 Richard O’Kennedy Award at Dublin City University, recognising her outstanding contributions to research, leadership, and academic excellence within the Faculty of Science and Health.

Prof. Silvia Giordani is pioneering the development of smart nanomaterials designed to transform how cancer drugs are delivered.